Cytokinetics

NASDAQ: CYTK · Real-Time Price · USD
38.63
-0.09 (-0.23%)
At close: Aug 15, 2025, 3:59 PM
39.20
1.46%
After-hours: Aug 15, 2025, 07:57 PM EDT

Cytokinetics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-606.31M -615.26M -589.53M -576.4M -545.28M -530.6M -526.24M -526.73M -539.62M -430.8M -388.95M -282.14M -215.92M -257.65M -215.31M -228.67M -155.76M -134.99M
Depreciation & Amortization
9.38M 9.5M 9.53M 13.48M 12.93M 12.38M 11.89M 7.21M 6.77M 6.32M 5.81M 4.89M 3.94M 3.08M 2.28M 2.01M 2.09M 1.96M
Stock-Based Compensation
102.69M 99.78M 97.84M 91.08M 84.44M 78.48M 72.06M 66.08M 60.53M 54.06M 47.85M 41.07M 35.66M 30.56M 26.83M 25M 21.92M 19.36M
Other Working Capital
-302K 56.1M 55.51M 39.25M 32.6M 2.06M 26.88M -7.43M -541K -69.74M -85.9M -74.26M -67.1M 37.11M 441.49M 513.32M 498.58M 484.41M
Other Non-Cash Items
72.03M 51.82M 50.6M 51.89M 41.66M 44.85M 48.09M 39.9M 60.69M 59.79M 60.48M 62.86M 42.55M 38.77M 32.38M 29.38M 24.43M 25.95M
Deferred Income Tax
n/a n/a n/a -23.23M -23.23M -23.23M -23.23M 1K 1K n/a n/a 2.84M 2.84M 2.84M 2.84M -573K -573K -573K
Change in Working Capital
-4.72M 56.16M 35.66M 38.83M 30.43M -3.44M 3.09M -24.95M -14.7M -84.37M -24.7M -75.58M -69.86M 42.59M 8.46M 127.22M 115.39M 97.86M
Operating Cash Flow
-426.92M -398M -395.89M -404.36M -399.06M -421.55M -414.33M -438.49M -426.32M -394.99M -299.52M -246.06M -200.79M -139.81M -142.52M -45.63M 7.5M 9.56M
Capital Expenditures
-13.55M -11.32M -3.91M -2.69M -458K 740K -1.42M -4.54M -10.65M -10.79M -11.34M -25.88M -35.25M -43.19M -48.87M -37.67M -24.57M -16.64M
Cash Acquisitions
n/a n/a n/a 81.33M 8.07M -74.77M -240.67M -354.46M 4.84M 21.56M 187.46M 219.92M -66.13M n/a n/a n/a n/a n/a
Purchase of Investments
-717.6M -1.31B -1.29B -1.4B -1.3B -688.09M -635.21M -534.27M -883.73M -752.04M -855.39M -761.81M -616.22M -651.97M -525.04M -762.73M -579.82M -491.43M
Sales Maturities Of Investments
959.04M 844.65M 744.23M 655.73M 676.66M 795.5M 875.88M 888.73M 878.88M 730.48M 604.59M 543.64M 491.08M 488.38M 426.14M 431.67M 343.35M 262.79M
Other Investing Acitivies
-3.25M 1.75M n/a -81.33M -9.83M 73.02M 240.67M 354.46M -4.84M -21.56M -250.8M -218.16M -125.14M -163.59M -98.91M -331.06M -236.47M -228.64M
Investing Cash Flow
224.65M -479.78M -553.1M -745.37M -627.28M 106.4M 239.25M 349.91M -15.5M -32.36M -262.13M -244.05M -160.39M -206.78M -147.78M -368.73M -261.04M -245.28M
Debt Repayment
-11.39M -11.57M -9.62M -6.93M -4.25M -1.58M -858K -741K 382.31M 382.25M 334.66M 334.77M -48.07M -47.8M n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a -10.52M 7.03M 8.87M 12.55M 17.54M n/a -1.84M -5.53M n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
786.62M 922.81M 933.91M 227.87M 280.99M 76M 57.94M 81.83M 34.89M 32.89M 181.5M 155.88M 450.58M 450.08M 304.84M 304.12M 4.45M 5.43M
Financial Cash Flow
89.1M 831.57M 930.61M 1.1B 1.15B 332.29M 221.32M 82.4M 417.2M 415.14M 516.17M 505.79M 417.66M 417.42M 319.98M 304.12M 229.55M 230.54M
Net Cash Flow
-113.97M -46.3M -18.17M -52.8M 121.5M 17.14M 46.22M -6.17M -24.62M -12.21M -45.48M 15.68M 56.48M 70.83M 29.68M -110.25M -23.98M -5.18M
Free Cash Flow
-440.48M -409.32M -399.8M -407.05M -399.52M -420.81M -415.75M -443.03M -436.98M -405.79M -310.85M -271.95M -236.05M -183M -191.39M -83.31M -17.06M -7.08M